These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 2407345

  • 1. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 2. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia.
    Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR.
    Cancer Res; 1990 Mar 15; 50(6):1803-9. PubMed ID: 2407344
    [Abstract] [Full Text] [Related]

  • 3. Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model.
    Garg PK, Garg S, Bigner DD, Zalutsky MR.
    Cancer Res; 1992 Sep 15; 52(18):5054-60. PubMed ID: 1516061
    [Abstract] [Full Text] [Related]

  • 4. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.
    Colapinto EV, Humphrey PA, Zalutsky MR, Groothuis DR, Friedman HS, de Tribolet N, Carrel S, Bigner DD.
    Cancer Res; 1988 Oct 15; 48(20):5701-7. PubMed ID: 3167830
    [Abstract] [Full Text] [Related]

  • 5. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F, Pfister C, Fournier K, Prevel F, Schreyer M, Carrel S, Mach JP.
    J Clin Invest; 1989 May 15; 83(5):1449-56. PubMed ID: 2708519
    [Abstract] [Full Text] [Related]

  • 6. Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
    Lee Y, Bullard DE, Humphrey PA, Colapinto EV, Friedman HS, Zalutsky MR, Coleman RE, Bigner DD.
    Cancer Res; 1988 May 15; 48(10):2904-10. PubMed ID: 2452014
    [Abstract] [Full Text] [Related]

  • 7. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 8. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM.
    Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.
    Li L, Xu HY, Mi L, Bian HJ, Qin J, Xiong H, Feng Q, Wen N, Tian R, Xu LQ, Shen XM, Tang H, Chen ZN.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1238-44. PubMed ID: 16979831
    [Abstract] [Full Text] [Related]

  • 10. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
    Schuster JM, Garg PK, Bigner DD, Zalutsky MR.
    Cancer Res; 1991 Aug 15; 51(16):4164-9. PubMed ID: 1714341
    [Abstract] [Full Text] [Related]

  • 11. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 12. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 14. Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.
    Worlock AJ, Zalutsky MR, Metzgar RS.
    Cancer Res; 1990 Nov 15; 50(22):7246-51. PubMed ID: 2224857
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunotherapy of human B-cell chronic lymphocytic leukemia in nude mice.
    Zhu Z, Ghose T, Hoskin D, Lee CL, Fernandez LA, Lee SH, Mammen M.
    Cancer Res; 1994 Oct 01; 54(19):5111-7. PubMed ID: 7923127
    [Abstract] [Full Text] [Related]

  • 16. Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
    Kraeber-Bodéré F, Faivre-Chauvet A, Saï-Maurel C, Campion L, Fiche M, Gautherot E, Le Boterff J, Barbet J, Chatal JF, Thédrez P.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3183s-3189s. PubMed ID: 10541362
    [Abstract] [Full Text] [Related]

  • 17. Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
    Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J.
    J Nucl Med; 2000 Mar 01; 41(3):480-7. PubMed ID: 10716323
    [Abstract] [Full Text] [Related]

  • 18. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.
    Boskovitz A, Akabani GH, Pegram CN, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2004 Apr 01; 31(3):345-55. PubMed ID: 15028247
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
    Lee YS, Bullard DE, Zalutsky MR, Coleman RE, Wikstrand CJ, Friedman HS, Colapinto EV, Bigner DD.
    Cancer Res; 1988 Feb 01; 48(3):559-66. PubMed ID: 2446747
    [Abstract] [Full Text] [Related]

  • 20. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.